Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.
D000818:Animals; D001419:Bacteria / Q000187:drug effects*; D001439:Bacteroides / Q000187:drug effects; D001769:Blood; D003470:Culture Media; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D004926:Escherichia coli / Q000187:drug effects; D006736:Horses; D007709:Klebsiella / Q000187:drug effects; D008826:Microbial Sensitivity Tests; D009343:Neisseria / Q000187:drug effects; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D012475:Salmonella / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013420:Sulfamethoxazole / Q000494:pharmacology*; D013936:Thymidine / Q000494:pharmacology; D014295:Trimethoprim / Q000494:pharmacology*; D014734:Vibrio cholerae / Q000187:drug effects
D003470:Culture Media; D004338:Drug Combinations; D014295:Trimethoprim; D013420:Sulfamethoxazole; D013936:Thymidine